Storia in 4 fonti

FDA fast-tracks psychedelic drug research following Trump executive order

It's a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use disorders, the FDA said.

Raccontata da

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

cnbc.comStai leggendo3 mesi fa

It's a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use disorders, the FDA said.

upi.com3 mesi fa

The FDA announced regulatory actions Friday to support development of serotonin-2A agonists and related products, including psychedelic drugs.